IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on June 27, 2025

Impact Score

2024-2025

4.48

h-Index

2024-2025

 157

Rank

2024-2025

 1785

SJR

2024-2025

 1.768

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Progress in Neuro-Psychopharmacology and Biological Psychiatry
Abbreviation Prog. Neuro-Psychopharmacol. Biol. Psychiatry
Publication Type Journal
Subject Area, Categories, Scope Biological Psychiatry (Q1); Pharmacology (Q1)
h-index 157
Overall Rank/Ranking 1785
SCImago Journal Rank (SJR) 1.768
Impact Score 4.48
Publisher Elsevier Inc.
Country United States
ISSN 18784216, 02785846
Best Quartile Q1
Coverage History 1982-2025




About Progress in Neuro-Psychopharmacology and Biological Psychiatry


Progress in Neuro-Psychopharmacology and Biological Psychiatry is a journal covering the technologies/fields/categories related to Biological Psychiatry (Q1); Pharmacology (Q1). It is published by Elsevier Inc.. The overall rank of Progress in Neuro-Psychopharmacology and Biological Psychiatry is 1785. According to SCImago Journal Rank (SJR), this journal is ranked 1.768. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 157. The best quartile for this journal is Q1.

The ISSN of Progress in Neuro-Psychopharmacology and Biological Psychiatry journal is 18784216, 02785846. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Progress in Neuro-Psychopharmacology and Biological Psychiatry is cited by a total of 3686 articles during the last 3 years (Preceding 2024).


Progress in Neuro-Psychopharmacology and Biological Psychiatry Impact IF 2024-2025


The Impact IF 2024 of Progress in Neuro-Psychopharmacology and Biological Psychiatry is 4.48, which is computed in 2025 as per its definition. Progress in Neuro-Psychopharmacology and Biological Psychiatry IF is decreased by a factor of 1.66 and approximate percentage change is -27.04% when compared to preceding year 2023, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Progress in Neuro-Psychopharmacology and Biological Psychiatry Impact IF 2025 Prediction


Impact IF 2024 of Progress in Neuro-Psychopharmacology and Biological Psychiatry is 4.48. If the same downward trend persists, Impact IF may fall in 2025 as well.


Impact IF Trend


Year wise Impact IF of Progress in Neuro-Psychopharmacology and Biological Psychiatry. Based on Scopus data.


Year Impact IF
2025/2026 Coming Soon
2024 4.48
2023 6.14
2022 6.11
2021 4.85
2020 4.72
2019 4.51
2018 4.45
2017 4.37
2016 4.50
2015 4.98
2014 4.21

Progress in Neuro-Psychopharmacology and Biological Psychiatry h-index


  Table Setting

Progress in Neuro-Psychopharmacology and Biological Psychiatry has an h-index of 157. It means 157 articles of this journal have more than 157 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Progress in Neuro-Psychopharmacology and Biological Psychiatry ISSN


The ISSN of Progress in Neuro-Psychopharmacology and Biological Psychiatry is 18784216, 02785846. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Progress in Neuro-Psychopharmacology and Biological Psychiatry Rank and SCImago Journal Rank (SJR)


The overall rank of Progress in Neuro-Psychopharmacology and Biological Psychiatry is 1785. According to SCImago Journal Rank (SJR), this journal is ranked 1.768. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Progress in Neuro-Psychopharmacology and Biological Psychiatry by Year


Year SJR
2025/2026 Coming Soon
2024 1.768
2023 1.652
2022 1.543
2021 1.370
2020 1.716
2019 1.714
2018 1.484
2017 1.714
2016 1.929
2015 1.819
2014 1.789

Ranking of Progress in Neuro-Psychopharmacology and Biological Psychiatry by Year


Year Ranking
2025/2026 Coming Soon
2024 1785
2023 1899
2022 2044
2021 2459
2020 1767
2019 1755
2018 2285
2017 1802
2016 1514
2015 1714
2014 1720

Progress in Neuro-Psychopharmacology and Biological Psychiatry Publisher


Table Setting

Progress in Neuro-Psychopharmacology and Biological Psychiatry is published by Elsevier Inc.. It's publishing house is located in United States. Coverage history of this journal is as following: 1982-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Progress in Neuro-Psychopharmacology and Biological Psychiatry is Prog. Neuro-Psychopharmacol. Biol. Psychiatry. This abbreviation ('Prog. Neuro-Psychopharmacol. Biol. Psychiatry') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Progress in Neuro-Psychopharmacology and Biological Psychiatry


If your research field is/are related to Biological Psychiatry (Q1); Pharmacology (Q1), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Progress in Neuro-Psychopharmacology and Biological Psychiatry?

Progress in Neuro-Psychopharmacology and Biological Psychiatry latest impact IF is 4.48. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 6.14 (2023) and 4.21 (2014), respectively, in the last 11 years. Moreover, its average IS is 4.85 in the previous 11 years.


What's the SCImago Journal Rank (SJR) of the Progress in Neuro-Psychopharmacology and Biological Psychiatry?

The Progress in Neuro-Psychopharmacology and Biological Psychiatry has an SJR (SCImago Journal Rank) of 1.768, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 1.929 in 2016 and the lowest being 1.370 in 2021. Furthermore, the average SJR of the Progress in Neuro-Psychopharmacology and Biological Psychiatry over the previous 11-year period stands at 4.85.


What's the latest h-index of the Progress in Neuro-Psychopharmacology and Biological Psychiatry?

The latest h-index of the Progress in Neuro-Psychopharmacology and Biological Psychiatry is 157.


Who's the publisher of the Progress in Neuro-Psychopharmacology and Biological Psychiatry?

The Progress in Neuro-Psychopharmacology and Biological Psychiatry is published by the Elsevier Inc., with its country of publication being the United States.


What's the current ranking of the Progress in Neuro-Psychopharmacology and Biological Psychiatry?

The Progress in Neuro-Psychopharmacology and Biological Psychiatry is currently ranked 1785 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 1514 in 2016 and its lowest position of 2459 in 2021.


What's the abbreviation or short name for the Progress in Neuro-Psychopharmacology and Biological Psychiatry?

The standard ISO4 abbreviation for the Progress in Neuro-Psychopharmacology and Biological Psychiatry is Prog. Neuro-Psychopharmacol. Biol. Psychiatry.


Is the "Progress in Neuro-Psychopharmacology and Biological Psychiatry" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Progress in Neuro-Psychopharmacology and Biological Psychiatry is classified as a journal that the Elsevier Inc. publishes.


What's the scope or major areas of the Progress in Neuro-Psychopharmacology and Biological Psychiatry?

The Progress in Neuro-Psychopharmacology and Biological Psychiatry encompasses the following areas:

  • Biological Psychiatry
  • Pharmacology

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Progress in Neuro-Psychopharmacology and Biological Psychiatry?

The Progress in Neuro-Psychopharmacology and Biological Psychiatry is assigned the following International Standard Serial Numbers (ISSN): 18784216, 02785846.


What's the best quartile of the Progress in Neuro-Psychopharmacology and Biological Psychiatry?

The best quartile for the Progress in Neuro-Psychopharmacology and Biological Psychiatry is Q1 (2024).


What's the coverage history of the Progress in Neuro-Psychopharmacology and Biological Psychiatry?

The Progress in Neuro-Psychopharmacology and Biological Psychiatry coverage history can be summarized as follows: 1982-2025.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Journal of Business Economics and Management journal 9811 Vilnius Gediminas Technical University 55 2.84
Zeitschrift fur Germanistische Linguistik journal 27452 Walter de Gruyter GmbH 17 0.29
Applied Ecology and Environmental Research journal 19122 Corvinus University of Budapest 48 0.84
Journal of Business Finance and Accounting journal 3244 Wiley-Blackwell Publishing Ltd 96 3.34
Air and Space Power Journal (discontinued) journal 28397 AU Press 9 0.20
Mathematical Modelling and Analysis journal 9616 Vilnius Gediminas Technical University 31 1.49
Libyan Studies journal 21508 Cambridge University Press 10 0.14
European Surgery - Acta Chirurgica Austriaca journal 18136 Springer Medizin 25 0.68
Population Review journal 19550 Sociological Demography Press 15 0.59
Proceedings of the Technical Association of the Graphic Arts, TAGA conference and proceedings 30903 Technical Association of the Graphic 8 0.00

Check complete list




Year wise Impact Score (IS) of Progress in Neuro-Psychopharmacology and Biological Psychiatry

Impact Score Table

Year Impact Score (IS)
2025/2026 Coming Soon
2024 4.48
2023 6.14
2022 6.11
2021 4.85
2020 4.72
2019 4.51
2018 4.45
2017 4.37
2016 4.50
2015 4.98
2014 4.21



Top Journals/Conferences in Biological Psychiatry

Lancet Psychiatry,The
Elsevier Ltd | United Kingdom

Biological Psychiatry
Elsevier Inc. | United States

Nature Mental Health
Springer Nature | United Kingdom

Translational Psychiatry
Springer Nature | United Kingdom

Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
Elsevier Inc. | United States

Journal of Abnormal Psychology
American Psychological Association | United States

European Neuropsychopharmacology
Elsevier B.V. | Netherlands

Brain Communications
Oxford University Press | United States

Psychiatry Research
Elsevier Ireland Ltd | Ireland

European Archives of Psychiatry and Clinical Neuroscience
D. Steinkopff-Verlag | Germany

See All

Top Journals/Conferences in Pharmacology

Nature Reviews Drug Discovery
Nature Research | United Kingdom

Pharmacological Reviews
Elsevier Inc. | United States

Drug Resistance Updates
Churchill Livingstone | United Kingdom

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

Annual Review of Pharmacology and Toxicology
Annual Reviews Inc. | United States

Molecular Therapy
Cell Press | United States

Pharmacology and Therapeutics
Elsevier Inc. | United States

Trends in Pharmacological Sciences
Elsevier Ltd | United Kingdom

Acta Pharmaceutica Sinica B
Chinese Academy of Medical Sciences | China

Theranostics
Ivyspring International Publisher | Australia

See All